Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system.
Neuro-ophthalmology update.
Is There Extra Cost of Institutional Care for MS Patients?
[Interferons and autoimmune diseases].
Lower Serum Levels of Th2-Related Chemokine CCL22 in Women Patients with Multiple Sclerosis: A Comparison Between Patients and Healthy Women.
Life on hold: the experience of living with neuromyelitis optica.
5-HT2 RECEPTORS FACILITATE JC POLYOMAVIRUS ENTRY.
Contribution of spinal cord biopsy to diagnosis of aquaporin-4 antibody positive neuromyelitis optica spectrum disorder.
Efficacy and safety of laquinimod in multiple sclerosis: current status.
Health status, work impediments, and coping related to work roles of women with multiple sclerosis.
Multiple sclerosis: Activation of cortical microglia linked to level of disability in patients with multiple sclerosis.
The diagnosis of multiple sclerosis and the various related demyelinating syndromes: A critical review.
A history of multiple sclerosis investigations in Canada between 1850 and 1950.
The right information can transform lives.
Immunophenotyping of Cerebrospinal Fluid Cells in Multiple Sclerosis: In Search of Biomarkers.
Cytokine-Regulated Neutrophil Recruitment Is Required for Brain but Not Spinal Cord Inflammation during Experimental Autoimmune Encephalomyelitis.
Dietary habits and selenium, glutathione peroxidase and total antioxidant status in the serum of patients with relapsing-remitting multiple sclerosis.
Levetiracetam for neuropathic pain in adults.
Th22 cells are expanded in multiple sclerosis and are resistant to IFN-β
Spinal cord tumour misdiagnosed as seropositive neuromyelitis optica spectrum disorder.
Science to practice: myeloperoxidase immunoradiology improves detection of acute and chronic experimental multiple sclerosis.
Zinc sulphate: A reasonable choice for depression management in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled clinical trial.
Cortical excitability changes over time in progressive multiple sclerosis.
Clinical Overview of Dalfampridine: An Agent With a Novel Mechanism of Action to Help With Gait Disturbances.
Treatment of cognitive impairment in multiple sclerosis: position paper.

Pages